(Q39244129)

English

Characterization of Prostate Cancer, Benign Prostatic Hyperplasia and Normal Prostates Using Transrectal31Phosphorus Magnetic Resonance Spectroscopy: A Preliminary Report

scientific article published on July 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Characterization of Prostate Cancer, Benign Prostatic Hyperplasia and Normal Prostates Using Transrectal31Phosphorus Magnetic Resonance Spectroscopy: A Preliminary Report (English)

reason for preferred rank

most precise value

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

author name string

P. Narayan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

P. Jajodia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

J. Kurhanewicz

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

A. Thomas

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

J. MacDonald

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

B. Hubesch

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

M. Hedgcock

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

C. M. Anderson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

T. L. James

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

E. A. Tanagho

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1711587

5 November 2022

language of work or name

0 references

publication date

1 July 1991

1 reference

Europe PubMed Central

10 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534717377169?httpAccept=text/xml

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

https://api.elsevier.com/content/article/PII:S0022534717377169?httpAccept=text/plain

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2937716-9

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Journal of Urology

1 reference

Europe PubMed Central

10 September 2017

146

1 reference

Europe PubMed Central

10 September 2017

66-74

1 reference

Europe PubMed Central

10 September 2017

1

1 reference

Europe PubMed Central

10 September 2017

Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases

1

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

NMR scanning of the pelvis: initial experience with a 0.3 T system

2

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Prostatic disorders: MR imaging at 1.5 T

3

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.

5

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

6

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance

8

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

9

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Monitoring response to chemotherapy of intact human tumours by 31P nuclear magnetic resonance

10

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Preoperative evaluation of localized prostatic carcinoma by transrectal ultrasonography

12

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Transrectal ultrasonography in the evaluation of patients with prostatic carcinoma

13

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy

14

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging

16

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

17

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues

19

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Androgen sensitivity of rat prostate carcinoma studied by 31P NMR spectroscopy, 1H MR imaging, and 23Na MR imaging

21

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Transrectal probe for 1H MRI and 31P MR spectroscopy of the prostate gland

22

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Isolation of a human prostate carcinoma cell line (DU 145)

23

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Morphometric and Clinical Studies on 68 Consecutive Radical Prostatectomies

25

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Intracellular pH determination by a 31P-NMR technique. The second dissociation constant of phosphoric acid in a biological system.

29

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Considerations for brain pH assessment by 31P NMR.

31

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Characterization of the 31P nuclear magnetic resonance spectrum from human melanoma tumors implanted in nude mice

34

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances

35

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Phosphate metabolites in lymphoid, Friend erythroleukemia, and HeLa cells observed by high-resolution 31P nuclear magnetic resonance

36

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

NMR studies of renal phosphate metabolites in vivo: effects of hydration and dehydration

40

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

31P nuclear magnetic resonance study of a human colon adenocarcinoma cultured cell line

41

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation

42

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Assessment of testicular metabolic integrity with P-31 MR spectroscopy

43

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Comparison of in vivo 31P-MR spectra of the brain, liver, and kidney of adult and infant animals.

44

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

1H- and 31P-NMR studies on smooth muscle of bullfrog stomach

45

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma

47

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma

48

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Breast tumors: evaluation with P-31 MR spectroscopy

51

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

31P magnetic resonance spectroscopy of human colon cancer

57

1 reference

10.1016/S0022-5347(17)37716-9

https://api.crossref.org/works/10.1016/S0022-5347(17)37716-9

5 November 2022

Identifiers

10.1016/S0022-5347(17)37716-9

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1711587

5 November 2022

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39244129&oldid=1765210396"